1. Home
  2. MDGL vs TAL Comparison

MDGL vs TAL Comparison

Compare MDGL & TAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • TAL
  • Stock Information
  • Founded
  • MDGL 2011
  • TAL 2003
  • Country
  • MDGL United States
  • TAL China
  • Employees
  • MDGL N/A
  • TAL N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • TAL Other Consumer Services
  • Sector
  • MDGL Health Care
  • TAL Real Estate
  • Exchange
  • MDGL Nasdaq
  • TAL Nasdaq
  • Market Cap
  • MDGL 6.1B
  • TAL 6.4B
  • IPO Year
  • MDGL N/A
  • TAL 2010
  • Fundamental
  • Price
  • MDGL $311.14
  • TAL $10.67
  • Analyst Decision
  • MDGL Strong Buy
  • TAL Buy
  • Analyst Count
  • MDGL 9
  • TAL 4
  • Target Price
  • MDGL $420.63
  • TAL $12.66
  • AVG Volume (30 Days)
  • MDGL 283.6K
  • TAL 4.0M
  • Earning Date
  • MDGL 08-06-2025
  • TAL 07-31-2025
  • Dividend Yield
  • MDGL N/A
  • TAL N/A
  • EPS Growth
  • MDGL N/A
  • TAL N/A
  • EPS
  • MDGL N/A
  • TAL 0.14
  • Revenue
  • MDGL $317,383,000.00
  • TAL $2,250,233,000.00
  • Revenue This Year
  • MDGL $286.17
  • TAL $33.54
  • Revenue Next Year
  • MDGL $64.17
  • TAL $23.96
  • P/E Ratio
  • MDGL N/A
  • TAL $76.74
  • Revenue Growth
  • MDGL N/A
  • TAL 50.98
  • 52 Week Low
  • MDGL $200.63
  • TAL $7.35
  • 52 Week High
  • MDGL $377.46
  • TAL $15.30
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 58.78
  • TAL 55.03
  • Support Level
  • MDGL $284.02
  • TAL $10.45
  • Resistance Level
  • MDGL $327.59
  • TAL $10.74
  • Average True Range (ATR)
  • MDGL 12.53
  • TAL 0.28
  • MACD
  • MDGL 2.52
  • TAL 0.02
  • Stochastic Oscillator
  • MDGL 67.07
  • TAL 65.57

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About TAL TAL Education Group

TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.

Share on Social Networks: